ulcerative colitis pipeline

Jun 25, 2026

Ulcerative colitis is a type of inflammatory bowel disease of unknown origin that targets the lining of the colon. Symptoms typically include diarrhea, abdominal pain, discomfort, and the presence of blood in the stool. The severity of the condition can vary, with inflammation affecting just the rectum, extending t...

Jul 14, 2025

Nearly two decades ago, treatment options for ulcerative colitis were limited, and selecting appropriate ulcerative colitis medications largely depended on disease severity and prior therapy response. Physicians often relied on combination approaches to optimize outcomes. Historically, the primary treatments for ul...

Oct 20, 2023

Bristol Myers Squibb’s Zeposia has lost its exclusive status as the sole S1P receptor modulator available for ulcerative colitis treatment. The FDA has granted approval for Pfizer’s ulcerative colitis medication, Etrasimod, under the brand name Velsipity. This decision comes after the publication of Phase III resul...